We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 964

Vitamin supplements can be medical treatment, Eighth Circuit says

  • Shook Hardy & Bacon LLP
  • -
  • Canada
  • -
  • August 7 2014

The Eighth Circuit has sided with Sun Life Assurance Co. of Canada in a lawsuit alleging that the insurance company improperly denied the plaintiff

Food, dietary supplement & cosmetics regulatory update, Issue 11

  • Jones Day
  • -
  • Canada, China, USA
  • -
  • August 8 2014

Last week, a divided federal appeals court ruled that FDA cannot be forced to ban antibiotics in food-producing healthy livestock. Thedecision comes

Privacy: what laws apply in Atlantic Canada?

  • Stewart McKelvey
  • -
  • Canada
  • -
  • August 1 2014

With increasing digitalization and the potential harm resulting from violations of an individual's privacy or unauthorized disclosure of one's

Plaintiff’s right to videorecord independent medical examinations andor to have a nominee present

  • Field Law
  • -
  • Canada
  • -
  • February 21 2013

The plaintiff sued for personal injury as a result of a motor vehicle accident that occurred on 14 November, 2007. The plaintiff alleged injuries to

Federal court affirms standing for innovative drug manufacturer

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 23 2014

What rights do innovative drug manufacturers have in situations where generics challenge certain Health Canada decisions but do not name the

Methods of medical treatment and dosage claims

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 28 2011

In Canada, claims to methods of medical treatment are considered to fall outside the definition of invention according to section 2 of the Patent Act and a decision of the Supreme Court of Canada

Toronto East General Hospital v. Gopinath

  • Harper Grey LLP
  • -
  • Canada
  • -
  • June 27 2014

A gastroenterologist ("Dr. Gopinath") secured a ruling from the Health Professions Appeal and Review Board ("Appeal Board") renewing his privileges

Teva v Pfizer, or the “Viagra saga”: if there is no quid proper disclosure there can be no quo exclusive monopoly rights

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada
  • -
  • November 19 2012

Sildenafil is the active ingredient in Viagra, the blockbuster potency-enhancing drug marketed by Pfizer

Reply affidavits allowed when new documents introduced in responding evidence

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 9 2014

In this case, there is a partial reversal of evidence. Apotex brought a motion for leave to file reply evidence. Allergan did not oppose parts of the

Federal Court grants injunction that allows infringing biologic drug to stay on the market

  • Norton Rose Fulbright Canada LLP
  • -
  • Canada
  • -
  • June 20 2014

Case: AbbVie Corporation, AbbVie Deutschland GMBH & Co. KG and AbbVie Biotechnology Ltd. v. Janssen Inc., 2014 FC 489 Drug: Ustekinumab (STELARA®